文献速递神经肿瘤小儿神经外科与脑积水

伴H3 K27M突变的弥漫性高级别胶质瘤预后不良且不依赖于肿瘤位置

Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location.
PubMed 文献 · Neuro Oncol · 2018-01-01

该研究对德国全国儿童HIT-HGG登记中85例经中心复核的中线部位弥漫性胶质瘤进行特征分析,发现56例为H3.3 K27M突变(66%)、6例为H3.1 K27M突变(7%)、23例为H3野生型(27%)。H3 K27M突变胶质瘤无论解剖位置均呈侵袭性临床过程,多因素回归证实H3 K27M突变是唯一独立预测总生存的指标(P=0.009),在突变肿瘤中中线位置、组织病理分级及切除程度均不影响生存。

要点

  • 多因素分析显示H3 K27M突变是唯一独立预测总生存的指标(P=0.009)。
  • H3 K27M突变肿瘤中中线位置、病理分级及切除程度均不影响生存。

核心结论

  • 结果证实应将弥漫性中线胶质瘤H3 K27M突变作为对应WHO IV级的独立实体,其预后普遍致命。

研究设计与样本

  • 基于德国全国儿童HIT-HGG登记,纳入85例经中心复核的中线部位弥漫性胶质瘤,分析肿瘤部位、组蛋白3突变状态、WHO分级、年龄、性别及肿瘤切除程度。

主要发现

  • 85例中H3.3 K27M突变56例(66%)、H3.1 K27M突变6例(7%)、H3野生型23例(27%)。
  • H3 K27M突变胶质瘤呈侵袭性临床过程且不依赖于解剖位置。
  • 多因素回归分析证实H3 K27M突变是唯一独立预测总生存的指标(P=0.009)。
  • 在H3 K27M突变肿瘤中,解剖中线位置、组织病理分级及肿瘤切除程度均对生存无影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The novel entity of "diffuse midline glioma, H3 K27M-mutant" has been defined in the 2016 revision of the World Health Organization (WHO) classification of tumors of the central nervous system (CNS). Tumors of this entity arise in CNS midline structures of predominantly pediatric patients and are associated with an overall dismal prognosis. They are defined by K27M mutations in H3F3A or HIST1H3B/C, encoding for histone 3 variants H3.3 and H3.1, respectively, which are considered hallmark events driving gliomagenesis. METHODS: Here, we characterized 85 centrally reviewed diffuse gliomas on midline locations enrolled in the nationwide pediatric German HIT-HGG registry regarding tumor site, histone 3 mutational status, WHO grade, age, sex, and extent of tumor resection. RESULTS: We found 56 H3.3 K27M-mutant tumors (66%), 6 H3.1 K27M-mutant tumors (7%), and 23 H3-wildtype tumors (27%). H3 K27M-mutant gliomas shared an aggressive clinical course independent of their anatomic location. Multivariate regression analysis confirmed the significant impact of the H3 K27M mutation as the only independent parameter predictive of overall survival (P = 0.009). In H3 K27M-mutant tumors, neither anatomic midline location nor histopathological grading nor extent of tumor resection had an influence on survival. CONCLUSION: These results substantiate the clinical significance of considering diffuse midline glioma, H3 K27M-mutant, as a distinct entity corresponding to WHO grade IV, carrying a universally fatal prognosis.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Karremann M, Gielen GH, Hoffmann M, et al. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Neuro Oncol. 2018. PMID: 29016894. doi:10.1093/neuonc/nox149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。